News

By using its T-cell receptor (TCR) engineering technology, Adaptimmune has created TCRs which are deployed to target the cancer testis antigen, NY-ESO-1, and other targets. The company’s trials

OsoBio is recognized as a premier contract manufacturer of highly complex injectable drug products, including sterile liquid, suspension and lyophilized formulations. The acquisition and associated fees are expected

As previously stated, Alexion believes that it has identified the process component that resulted in the presence of the visible particles and implemented a change to the process.

Theravance, Inc., A Royalty Management Company, is focused on maximizing the potential value of the respiratory assets partnered with GlaxoSmithKline plc including RELVAR/BREO ELLIPTA and ANORO ELLIPTA and

The new business will become Horizon CombinatoRx Incorporated, a wholly owned subsidiary of Horizon. Horizon CombinatoRx, Inc. will be located in 23,000 sq. ft. of laboratory and office

The company is carrying out the development of the RSV vaccine, as part of the TechnoVax program, using its proprietary VLP technology, which is a new way to

The results showed that the combination was generally well tolerated and produced evidence of clinical response. In the trial, 42% of immunotherapy-naïve patients who received ipilimumab with INCB24360

Around 10,000 patients with severe burns are hospitalized every year in South Korea and primarily are treated at about 10 burn centers. The easy-to-use, topically-applied pharmaceutical product ‘NexoBrid’

Nuvigil is a prescription medicine indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), shift work disorder (SWD) or narcolepsy. As